Literature DB >> 24162770

Lacrimal sac dacryolith (76 cases): a predictive factor for successful endonasal dacryocystorhinostomy?

Pavel Komínek1, Stanislav Červenka, Karol Zeleník, Tomáš Pniak, Hana Tomášková, Petr Matoušek.   

Abstract

To evaluate whether the presence of dacryolith is a predictive factor for successful dacryocystorhinostomy. The success rate of endonasal dacryocystorhinostomy (EDCR) performed to relieve obstruction of the nasolacrimal duct was evaluated according to the presence of dacryolithiasis. The surgical results of patients with (group I) and without dacryoliths (group II) were analysed and compared 1-year post surgery. A total of 771 EDCRs performed from 1994 to 2010 were evaluated. Dacryolith was found in 76/771 procedures (9.9%). Complete improvement was achieved significantly more frequently in group I (76/76; 100.0%) than in group II (633/695; 91.1%; p < 0.001). EDCRs were performed significantly more frequently in people aged 31-50-years, the average age of the group I was 41.1 years (range 18-72 years), of the group II 53.3 years (range 3 months-86 years; p < 0.001). There was no significant difference in the female-to-male ratio in the two groups. The presence of dacryoliths is a predictive factor for successful endonasal dacryocystorhinostomy.

Entities:  

Mesh:

Year:  2013        PMID: 24162770     DOI: 10.1007/s00405-013-2787-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  18 in total

1.  Chronic inflammation: a poor prognostic factor for endoscopic dacryocystorhinostomy.

Authors:  Ozlem Ozer; Görkem Eskiizmir; Halis Unlü; Aydin Işisağ; Asim Aslan
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-11       Impact factor: 2.503

2.  Factors associated with outcome of endonasal dacryocystorhinostomy.

Authors:  Dena S Hammoudi; Nancy A Tucker
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2011 Jul-Aug       Impact factor: 1.746

3.  Lacrimal sac calculi.

Authors:  S Herzig; J J Hurwitz
Journal:  Can J Ophthalmol       Date:  1979-01       Impact factor: 1.882

4.  Diagnosis and incidence of lacrimal calculi.

Authors:  R B Wilkins; J P Pressly
Journal:  Ophthalmic Surg       Date:  1980-11

5.  Lacrimal system dacryoliths.

Authors:  A J Berlin; R Rath; L Rich
Journal:  Ophthalmic Surg       Date:  1980-07

6.  The prognostic value of preoperative dacryocystography in endoscopic intranasal dacryocystorhinostomy.

Authors:  G E Mannor; A L Millman
Journal:  Am J Ophthalmol       Date:  1992-02-15       Impact factor: 5.258

7.  Lacrimal sac dacryoliths: predictive factors and clinical characteristics.

Authors:  B Yazici; A M Hammad; D R Meyer
Journal:  Ophthalmology       Date:  2001-07       Impact factor: 12.079

8.  An eyelash nidus for dacryoliths of the lacrimal excretory and secretory systems.

Authors:  K H Baratz; G B Bartley; R J Campbell; J A Garrity
Journal:  Am J Ophthalmol       Date:  1991-05-15       Impact factor: 5.258

9.  Clinical presentation of patients with dacryolithiasis.

Authors:  Petros Andreou; Geoffrey E Rose
Journal:  Ophthalmology       Date:  2002-08       Impact factor: 12.079

10.  The surgical outcome of endoscopic dacryocystorhinostomy according to the obstruction levels of lacrimal drainage system.

Authors:  Ji Chul Choi; Hong-Ryul Jin; Young Eun Moon; Min-Sang Kim; Jae Kwang Oh; Hyun Ah Kim; Mi-Young Choi; Woo Sub Shim
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-09-23       Impact factor: 3.372

View more
  3 in total

Review 1.  [Recognition and prevention of problems in lacrimal duct surgery].

Authors:  T Kühnel
Journal:  HNO       Date:  2018-06       Impact factor: 1.284

2.  Retained Herrick Plug.

Authors:  Justin B Hellman; Edward Bradley Strong; Lily Koo Lin
Journal:  Case Rep Ophthalmol       Date:  2018-05-24

3.  Long-term Efficacy of Dacryoendoscopy-guided Recanalization and Silicone Tube Intubation.

Authors:  Sung Eun Kim; Jin Uk Beak; Ji-Sun Paik; Juwan Park; Suk-Woo Yang
Journal:  Korean J Ophthalmol       Date:  2022-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.